APA (7th ed.) Citation

Alorfi, N. M., Alshehri, F. S., Ashour, A. M., Aldurdunji, M. M., Alkhanani, M. F., Alhasani, R. H., . . . Chauhan, A. (2026). Therapeutics for Rheumatoid Arthritis: A Phase 4 Clinical Trial Analysis With a Focus on Disability Outcomes. Journal of Clinical Pharmacy & Therapeutics, 2026, 1. https://doi.org/10.1155/jcpt/8453371

Chicago Style (17th ed.) Citation

Alorfi, Nasser M., Fahad S. Alshehri, Ahmed M. Ashour, Mohammed M. Aldurdunji, Mustfa Faisal Alkhanani, Reem Hasaballah Alhasani, Mohammed S. Alharthi, Nasser M. Aldekhail, and Anjali Chauhan. "Therapeutics for Rheumatoid Arthritis: A Phase 4 Clinical Trial Analysis With a Focus on Disability Outcomes." Journal of Clinical Pharmacy & Therapeutics 2026 (2026): 1. https://doi.org/10.1155/jcpt/8453371.

MLA (9th ed.) Citation

Alorfi, Nasser M., et al. "Therapeutics for Rheumatoid Arthritis: A Phase 4 Clinical Trial Analysis With a Focus on Disability Outcomes." Journal of Clinical Pharmacy & Therapeutics, vol. 2026, 2026, p. 1, https://doi.org/10.1155/jcpt/8453371.